Analysts lifted targets across semiconductors and healthcare diagnostics this week, while a broad wave of cuts swept through the utility sector.
Oppenheimer raised its price target on NXPI to $325 from $300, maintaining a Buy rating. NXP Semiconductors carries a $68 billion market cap. Short interest sits at just 3.5% of free float, suggesting little bearish conviction from traders.
INTC also got a boost. Morgan Stanley lifted its target to $84 from $75. The analyst kept a Hold rating, but the $9 move is the largest percentage jump Intel has seen from that firm in recent quarters.
Mizuho upgraded its target on DGX sharply, moving to $260 from $235. Quest Diagnostics has a $25 billion market cap. Short sellers are not heavily positioned — SI sits at just 4% of free float.
Toy maker HAS also attracted a higher target. The consensus average target price rose to $108.92 from $108.15. Short interest is 6% of free float, moderate for a consumer name.
Meanwhile, utilities took hits across the board. DUK, , , , , , , and all saw consensus target prices trimmed. The cuts are small in dollar terms but reflect a coordinated sector reassessment, likely driven by rising rate sensitivity and grid cost pressures.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
